Shield blood test for colorectal cancer screening
Part of Cancer, Digestive system clinical trials.
This study is testing the Shield blood test for people at average risk of colorectal cancer. It looks at how well the test works for screening, so you can learn about your risk with a simple blood draw.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 45 and 81 years old
- You plan to get the Shield blood test as part of your regular care
- Your doctor says you are at average risk for colorectal cancer (no symptoms, no personal or family history of it)
- You agree to follow the study steps and any standard follow-up tests
- You have not had a positive colorectal cancer screening test in the last 6 months (or longer for some stool tests)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps people understand their Shield+ cancer screening results and provides counseling to support decision-making. Researchers want to learn how best to communicate test results and help people know what to do next.
This trial tests a new blood test to screen for colorectal cancer in people at average risk. You would give a blood sample before your scheduled colonoscopy, and the results will be compared to the colonoscopy findings.
This study tests a new blood test that might help detect colorectal cancer. If you're already planning a colonoscopy or colorectal surgery, your participation could help improve early detection.
This trial is testing a blood test called Guardant Shield to see if it can effectively screen for colorectal cancer (a common cancer of the colon or rectum). If you're between 45 and 85 and overdue for a screening, this test could be a simpler alternative to colonoscopy or stool tests.
This study checks whether a blood test can help identify colorectal cancer or precancerous growths. You would have a planned colonoscopy, and researchers compare the blood test results to what the colonoscopy finds.
This study is testing a new blood test (Signal-C) to see if it can help find colorectal cancer early. You may be able to join if you are average risk and getting a routine screening colonoscopy.
Hear when a new Colo-rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.